VC FundEIF
🇫🇷 Sofinnova Partners
Paris, France
Fund size
€600M
Capital XI
Stages
Series A, Series B
Focus
Health & Bio
Region
France
About Sofinnova Partners
Sofinnova Partners is a life sciences venture capital firm based in Paris, investing at Series A and Series B in healthcare, biotech and medtech. Its Capital XI fund closed at around EUR 650M in 2025 to back 50 to 60 early-stage companies across Europe and North America, and the firm is backed by the EIF.
Notable portfolio
GenSightAbivaxDNA Script
EUACC IntelligenceFree preview
EUACC Intelligence
Ask about Sofinnova Partners
Get instant answers about Sofinnova Partners and how it fits your raise.